Terumo Corporation (FRA:TUO)

Market Cap	15.86B -43.1%
Revenue (ttm)	5.95B +8.3%
Net Income	694.79M +2.2%
EPS	0.47 +2.8%
Shares Out	n/a
PE Ratio	22.82
Forward PE	n/a
Dividend	0.17 (1.51%)
Ex-Dividend Date	Sep 29, 2025

Volume	100
Average Volume	114
Open	11.00
Previous Close	11.00
Day's Range	11.00 - 11.00
52-Week Range	10.30 - 18.60
Beta	n/a
RSI	46.79
Earnings Date	Feb 13, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. It operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents, intravascular ultrasound systems,...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TUO

Financial Performance

In fiscal year 2025, Terumo's revenue was 1.04 trillion, an increase of 12.40% compared to the previous year's 921.86 billion. Earnings were 116.98 billion, an increase of 9.97%.

Financial numbers in JPY